CA2144882A1 - Vaccin a base de peptide synthetique contre chlamydia trachomatis - Google Patents

Vaccin a base de peptide synthetique contre chlamydia trachomatis

Info

Publication number
CA2144882A1
CA2144882A1 CA002144882A CA2144882A CA2144882A1 CA 2144882 A1 CA2144882 A1 CA 2144882A1 CA 002144882 A CA002144882 A CA 002144882A CA 2144882 A CA2144882 A CA 2144882A CA 2144882 A1 CA2144882 A1 CA 2144882A1
Authority
CA
Canada
Prior art keywords
peptide
epitope
synthetic peptide
cell
trachomatis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002144882A
Other languages
English (en)
Inventor
Harlan D. Caldwell
Hua Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2144882A1 publication Critical patent/CA2144882A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002144882A 1992-09-18 1993-09-14 Vaccin a base de peptide synthetique contre chlamydia trachomatis Abandoned CA2144882A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94767192A 1992-09-18 1992-09-18
US07/947,671 1992-09-18

Publications (1)

Publication Number Publication Date
CA2144882A1 true CA2144882A1 (fr) 1994-03-31

Family

ID=25486544

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002144882A Abandoned CA2144882A1 (fr) 1992-09-18 1993-09-14 Vaccin a base de peptide synthetique contre chlamydia trachomatis

Country Status (5)

Country Link
EP (1) EP0662083A1 (fr)
JP (1) JPH08504188A (fr)
AU (1) AU669000B2 (fr)
CA (1) CA2144882A1 (fr)
WO (1) WO1994006827A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516293D0 (en) * 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
IL121115A (en) * 1997-06-19 2001-06-14 Savyon Diagnostics Ltd C. trachomatis specific peptides and their use in diagnostic assays
US6555115B1 (en) * 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
EP1278855B1 (fr) 2000-04-21 2008-03-12 Corixa Corporation Composes et procedes pour le traitement et le diagnostic d'une infection de chlamydia
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP1885393A4 (fr) * 2005-05-18 2011-03-02 Childrens Hosp & Res Ct Oak Procédés et compositions permettant l'immunisation contre les infections à chlamydia
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
US9308248B2 (en) 2011-06-17 2016-04-12 Universiteit Gent Vaccines for Chlamydia
LT2976355T (lt) 2013-03-18 2020-04-10 Statens Serum Institut Vakcinos prieš chlamydia sp.
AR132053A1 (es) 2023-03-02 2025-05-21 Sanofi Pasteur Composiciones para su uso en el tratamiento de clamidia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348725A3 (fr) * 1988-06-29 1990-10-24 Miles Inc. Epitode spécifique de l'espèce de chlamydia trachomatis et les anticorps le reconnaissant

Also Published As

Publication number Publication date
EP0662083A1 (fr) 1995-07-12
AU669000B2 (en) 1996-05-23
JPH08504188A (ja) 1996-05-07
AU4925093A (en) 1994-04-12
WO1994006827A1 (fr) 1994-03-31

Similar Documents

Publication Publication Date Title
Su et al. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein.
AU704502B2 (en) Non-dendritic backbone peptide carrier
ES2123558T5 (es) Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.
CA2253374C (fr) Nouveaux fragments peptidiques derives de ospc
EP0550599B1 (fr) Peptides destines a etre utilises dans la vaccination et dans l'induction d'anticorps neutralisants pour lutter contre le virus d'immunodeficience humaine
AU669000B2 (en) Synthetic peptide vaccine for chlamydia trachomatis
Su et al. Immunogenicity of a synthetic oligopeptide corresponding to antigenically common T-helper and B-cell neutralizing epitopes of the major outer membrane protein of Chlamydia trachomatis
Hoogerhout et al. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis
JPH08509692A (ja) Ｅ型肝炎ウイルスペプチド抗原および抗体
HUT63179A (en) Process for producing synthetic polypeptides
US6716574B2 (en) Osp-C derived peptide fragments
EP0846176A1 (fr) Proteine hybride renfermant des epitopes de stimulation des lymphocytes t auxiliaires et des epitopes de lymphocytes b provenant de la proteine de la membrane externe principale de chlamydia trachomatis et son utilisation comme vaccin
EP0740792B1 (fr) Peptomeres a immunogenicite accrue
US7169393B2 (en) Antigenic peptide fragments of VapA protein, and uses thereof
EP1174506A1 (fr) Le peptide C-terminal de Erns et ses analogues
CA2719041C (fr) Compositions, procedes et kits
EP0348725A2 (fr) Epitode spécifique de l'espèce de chlamydia trachomatis et les anticorps le reconnaissant
AU2010312300A1 (en) Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
Joisson et al. Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides
JPH04507409A (ja) 風疹ｅ１ペプチド
Chong et al. Structural and functional analysis of the SI subunit of pertussis toxin using synthetic peptides
ES2202321T3 (es) Peptidos para uso en la vacunacion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
WO2005018538A2 (fr) Polypeptides du sras (syndrome respiratoire aigu severe), et anticorps desdits polypeptides et leur utilisation a des fins de diagnostics, vaccination, et applications therapeutiques
Raupach et al. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections
AU2001252038B2 (en) Antigenic peptide fragments of vapa protein, and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued